Tata Institute develops tablet for cancer recurrence prevention
India’s Tata Institute of Fundamental Research (TIFR) has brought the improvement of a manufacturer new pro-oxidant tablet, combining resveratrol and copper (R+Cu), that has the potential to forestall the recurrence of cancer. greater than a decade of research on the Tata Memorial….